Aura Biosciences, Inc. Other Current Assets
Aura Biosciences, Inc. (AURA) had Other Current Assets of $819.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Current $819.00K.
- 2026-03-31: Other Assets, Current $1.06M.
- 2025-12-31: Other Assets, Current $660.00K; Other Assets, Current as first filed $1.18M.
- 2025-09-30: Other Assets, Current $2.58M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $819.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.06M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $660.00K 10-Q · filed 2026-08-11 | $1.18M 10-K · filed 2026-03-30 |
| 2025-09-30 | $2.58M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.62M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.77M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.83M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $3.42M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.47M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.29M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.41M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $566.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $988.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $771.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $715.00K 10-K · filed 2024-03-27 | $712.00K 10-K · filed 2023-03-15 |
| 2022-09-30 | $306.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $261.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $131.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $66.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $55.00K 10-Q · filed 2021-11-24 | |
| 2020-12-31 | $16.00K 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |